Protocol for base resolution mapping of ac4C using RedaC:T-seq

0303 health sciences Science (General) DNA, Complementary Bioinformatics High-Throughput Nucleotide Sequencing Cytidine RNAseq Q1-390 03 medical and health sciences Protocol Sequencing Molecular Biology Thymidine
DOI: 10.1016/j.xpro.2022.101858 Publication Date: 2022-11-16T23:03:27Z
ABSTRACT
N4-acetylcytidine (ac4C) is an mRNA modification catalyzed by the enzyme N-acetyltransferase 10 (NAT10), with position-dependent effects on mRNA translation. This protocol details a procedure to map ac4C at base resolution using NaBH4-induced reduction of ac4C and conversion to thymidine followed by sequencing (RedaC:T-seq). Total RNA is ribodepleted and then treated with NaBH4 to reduce ac4C to tetrahydro-ac4C, which specifically alters base pairing during cDNA synthesis, allowing the detection of ac4C at positions called as thymidine following Illumina sequencing. For complete details on the use and execution of this protocol, please refer to Arango et al. (2022).1.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (13)
CITATIONS (9)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....